Psycho-existential distress in cancer patients: A return to "entheogens"

Affiliations

¹ Adult Palliative Care Service, Department of Medicine, Columbia University Medical Center/NewYork-Presbyterian Hospital, New York, NY, USA cdb21@cumc.columbia.edu.

Comment

Craig D Blinderman. J Psychopharmacol. 2016 Dec.

. 2016 Dec;30(12):1205-1206.

doi: 10.1177/0269881116675761.

¹ Adult Palliative Care Service, Department of Medicine, Columbia University Medical Center/NewYork-Presbyterian Hospital, New York, NY, USA cdb21@cumc.columbia.edu.

No abstract available

Comment on

Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial.
Ross S, Bossis A, Guss J, Agin-Liebes G, Malone T, Cohen B, Mennenga SE, Belser A, Kalliontzi K, Babb J, Su Z, Corby P, Schmidt BL. Ross S, et al. J Psychopharmacol. 2016 Dec;30(12):1165-1180. doi: 10.1177/0269881116675512. J Psychopharmacol. 2016. PMID: 27909164 Free PMC article. Clinical Trial.
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial.
Griffiths RR, Johnson MW, Carducci MA, Umbricht A, Richards WA, Richards BD, Cosimano MP, Klinedinst MA. Griffiths RR, et al. J Psychopharmacol. 2016 Dec;30(12):1181-1197. doi: 10.1177/0269881116675513. J Psychopharmacol. 2016. PMID: 27909165 Free PMC article. Clinical Trial.